These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11746716)

  • 1. Cholinergic neuronal modulations affect striatal dopamine transporter activity: PET studies in the conscious monkey brain.
    Tsukada H; Nishiyama S; Ohba H; Sato K; Harada N; Kakiuchi T
    Synapse; 2001 Dec; 42(3):193-5. PubMed ID: 11746716
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    J Neurosci; 2000 Sep; 20(18):7067-73. PubMed ID: 10995853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
    Synapse; 2001 Dec; 42(4):273-80. PubMed ID: 11746726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation of dopaminergic neural transmission does not affect [(11)C]SCH23390 binding to the striatal D(1) dopamine receptors, but the facilitation enhances phosphodiesterase type-IV activity through D(1) receptors: PET studies in the conscious monkey brain.
    Tsukada H; Harada N; Ohba H; Nishiyama S; Kakiuchi T
    Synapse; 2001 Dec; 42(4):258-65. PubMed ID: 11746724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
    Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
    Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
    Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic and nicotinic cholinergic receptor antagonists differentially mediate acquisition of fructose-conditioned flavor preference and quinine-conditioned flavor avoidance in rats.
    Rotella FM; Olsson K; Vig V; Yenko I; Pagirsky J; Kohen I; Aminov A; Dindyal T; Bodnar RJ
    Neurobiol Learn Mem; 2015 Sep; 123():239-49. PubMed ID: 26188277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioral, and physiologic responses.
    Little JT; Johnson DN; Minichiello M; Weingartner H; Sunderland T
    Neuropsychopharmacology; 1998 Jul; 19(1):60-9. PubMed ID: 9608577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain.
    Kilbourn MR; Kemmerer ES; Desmond TJ; Sherman PS; Frey KA
    Exp Neurol; 2004 Aug; 188(2):387-90. PubMed ID: 15246838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal long term memory: effect of the cholinergic system on local protein synthesis.
    Lana D; Cerbai F; Di Russo J; Boscaro F; Giannetti A; Petkova-Kirova P; Pugliese AM; Giovannini MG
    Neurobiol Learn Mem; 2013 Nov; 106():246-57. PubMed ID: 24076274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Tissingh G; Bergmans P; Winogrodzka A; Stoof JC; Wolters EC; Booij J; Van Royen EA
    J Nucl Med; 1997 Aug; 38(8):1271-2. PubMed ID: 9255164
    [No Abstract]   [Full Text] [Related]  

  • 13. Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding.
    Happe S; Pirker W; Klösch G; Sauter C; Zeitlhofer J
    J Neurol; 2003 Jan; 250(1):83-6. PubMed ID: 12527997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine.
    Gatley SJ; Volkow ND; Fowler JS; Dewey SL; Logan J
    Synapse; 1995 Jun; 20(2):137-44. PubMed ID: 7570343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
    Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
    Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine.
    Hashimoto K; Tsukada H; Nishiyama S; Fukumoto D; Kakiuchi T; Shimizu E; Iyo M
    Neuropsychopharmacology; 2004 Nov; 29(11):2018-23. PubMed ID: 15199373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of nicotinic and muscarinic acetylcholine receptors on striatal HgCl2-induced dopamine release in freely moving rats.
    Vidal L; Durán R; Faro LR; Alfonso M
    Toxicol Lett; 2008 May; 178(3):181-4. PubMed ID: 18439770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine transporter imaging in nonhuman primates with iodine-123-IPT SPECT.
    Malison RT; Vessotskie JM; Kung MP; McElgin W; Romaniello G; Kim HJ; Goodman MM; Kung HF
    J Nucl Med; 1995 Dec; 36(12):2290-7. PubMed ID: 8523122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.